By activating GLP-1 receptors in the hypothalamus and brainstem, these analogs promote satiety, leading to reduced food intake and weight loss ( Studies as Network Meta-analysis and clinical trials have shown that GLP1-RA can achieve a statistically significant decrease in HbA1C compared to placebo, as well as a weight reduction ranging between 1.3 and 8.65 kg ( With regard to cardioprotection, several mechanisms have been proposed
Women combining both therapies tend to lose meaningfully more weight than those on GLP-1s alone, giving the combination a real edge over either treatment on its own
The GLP-1 agonists bind to receptors in the brain, pancreas and intestines, which helps to regulate insulin release, lower blood sugar levels, slow down digestion, and reduce appetite
& Fink, W.J
Newer medications coming through the pipeline may also be relevant to mention
- Support for Vegans and Vegetarians: Individuals following plant-based diets often benefit from supplementation